PRNewsWire
06 Feb 2026, 16:41 UTC · 32w ago
Verdict
Headline takes no side. We score RARE −1.00 — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a class action lawsuit following a 42% stock price drop after Phase 3 clinical trials failed to meet primary endpoints.
More negative than 89% of ticker scores this week
The company is the subject of a class action lawsuit filing.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 89% of ticker scores this week
The company is the subject of a class action lawsuit filing.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
2d ago
−39.0%
Price agrees with the score
$14.51 vs $23.79 close before publication (Feb 5) · not market-adjusted
RARE chart →
